Your browser doesn't support javascript.
loading
Hyperbaric oxygen treatment on keloid tumor immune gene expression.
Wang, Chun-Hu; Shan, Meng-Jie; Liu, Hao; Hao, Yan; Song, Ke-Xin; Wu, Huan-Wen; Meng, Tian; Feng, Cheng; Qi, Zheng; Wang, Zhi; Wang, You-Bin.
Afiliação
  • Wang CH; 17th Department of Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100144, China.
  • Shan MJ; Department of Plastic Surgery, Peking Union Medical College Hospital, Beijing 100730, China.
  • Liu H; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Hao Y; Department of Plastic Surgery, Peking Union Medical College Hospital, Beijing 100730, China.
  • Song KX; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Wu HW; Department of Plastic Surgery, Peking Union Medical College Hospital, Beijing 100730, China.
  • Meng T; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Feng C; Department of Plastic Surgery, Peking Union Medical College Hospital, Beijing 100730, China.
  • Qi Z; Department of Pathology, Peking Union Medical College Hospital, Beijing 100730, China.
  • Wang Z; Department of Plastic Surgery, Peking Union Medical College Hospital, Beijing 100730, China.
  • Wang YB; Department of Plastic Surgery, Peking Union Medical College Hospital, Beijing 100730, China.
Chin Med J (Engl) ; 134(18): 2205-2213, 2021 Sep 13.
Article em En | MEDLINE | ID: mdl-34553702
ABSTRACT

BACKGROUND:

Hyperbaric oxygen treatment (HBOT) has been demonstrated to influence the keloid recurrence rate after surgery and to relieve keloid symptoms and other pathological processes in keloids. To explore the mechanism of the effect of HBOT on keloids, tumor immune gene expression and immune cell infiltration were studied in this work.

METHODS:

From February 2021 to April 2021, HBOT was carried out on keloid patients four times before surgery. Keloid tissue samples were collected and divided into an HBOT group (keloid with HBOT before surgery [HK] group, n = 6) and a non-HBOT group (K group, n = 6). Tumor gene expression was analyzed with an Oncomine Immune Response Research Assay kit. Data were mined with R package. The differentially expressed genes between the groups were compared. Hub genes between the groups were determined and verified with Quantitative Real-time PCR. Immune cell infiltration was analyzed based on CIBERSORT deconvolution algorithm analysis of gene expression and verified with immunohistochemistry (IHC).

RESULTS:

Inflammatory cell infiltration was reduced in the HK group. There were 178 upregulated genes and 217 downregulated genes. Ten hub genes were identified, including Integrin Subunit Alpha M (ITGAM), interleukin (IL)-4, IL-6, IL-2, Protein Tyrosine Phosphatase Receptor Type C (PTPRC), CD86, transforming growth factor (TGF), CD80, CTLA4, and IL-10. CD80, ITGAM, IL-4, and PTPRC with significantly downregulated expression were identified. IL-10 and IL-2 were upregulated in the HK group but without a significant difference. Infiltration differences of CD8 lymphocyte T cells, CD4 lymphocyte T-activated memory cells, and dendritic resting cells were identified with gene CIBERSORT deconvolution algorithm analysis. Infiltration levels of CD4 lymphocyte T cell in the HK group were significantly higher than those of the K group in IHC verification.

CONCLUSION:

HBOT affected tumor gene expression and immune cell infiltration in keloids. CD4 lymphocyte T cell, especially activated memory CD4+T, might be the key regulatory immune cell, and its related gene expression needs further study.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxigenoterapia Hiperbárica / Queloide / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxigenoterapia Hiperbárica / Queloide / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article